Resources Management Corp Abb Vie Inc. Transaction History

Resources Management Corp

$741 Million
Q3 2024

A detailed history of Resources Management Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Resources Management Corp holds 80,810 shares of ABBV stock, worth $13.6 Million. This represents 2.15% of its overall portfolio holdings.

Number of Shares

80,810

Previous 81,355 0.67%

Holding current value

$13.6 Million

Previous $14 Million 14.36%

% of portfolio

2.15%

Previous 2.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$163.84 - $199.33 $89,292 - $108,634	-545 Reduced 0.67%	80,810 $16 Million
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $59,284 - $69,231	383 Added 0.47%	81,355 $14 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $1.07 Million - $1.22 Million	-6,674 Reduced 7.61%	80,972 $14.7 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $12 Million - $13.6 Million	87,491 Added 56445.81%	87,646 $13.6 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $12 Million - $13.5 Million	-87,421 Reduced 99.82%	155 $13.6 Million
Q3 2023 Nov 16, 2023	BUY	$133.59 - $154.65 $2,538 - $2,938	19 Added 0.02%	87,576 $13.1 Million
Q2 2023 Aug 16, 2023	SELL	$132.51 - $164.9 $19.5 Million - $24.2 Million	-147,032 Reduced 62.68%	87,557 $11.8 Million
Q1 2023 May 11, 2023	BUY	$144.61 - $166.54 $21.1 Million - $24.3 Million	146,145 Added 165.24%	234,589 $38.7 Million
Q4 2022 Feb 08, 2023	SELL	$138.31 - $165.87 $81,187 - $97,365	-587 Reduced 0.66%	88,444 $14.3 Million
Q3 2022 Nov 15, 2022	BUY	$134.21 - $153.93 $83,881 - $96,206	625 Added 0.71%	89,031 $11.9 Million
Q2 2022 Aug 10, 2022	BUY	$137.62 - $174.96 $10,871 - $13,821	79 Added 0.09%	88,406 $13.5 Million
Q1 2022 May 20, 2022	SELL	$131.98 - $163.75 $403,858 - $501,075	-3,060 Reduced 3.35%	88,327 $14.3 Million
Q4 2021 Feb 04, 2022	BUY	$107.43 - $135.93 $143,419 - $181,466	1,335 Added 1.48%	91,387 $12.4 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $8,512 - $9,662	80 Added 0.09%	90,052 $9.71 Million
Q2 2021 Aug 10, 2021	SELL	$105.21 - $117.21 $99,213 - $110,529	-943 Reduced 1.04%	89,972 $10.1 Million
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $6,649 - $7,320	65 Added 0.07%	90,915 $9.84 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $42,015 - $56,725	-522 Reduced 0.57%	90,850 $9.74 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $80,497 - $94,477	937 Added 1.04%	91,372 $8 Million
Q2 2020 Aug 11, 2020	BUY	$73.37 - $98.18 $77,111 - $103,187	1,051 Added 1.18%	90,435 $8.88 Million
Q1 2020 May 04, 2020	SELL	$64.5 - $97.79 $264,127 - $400,450	-4,095 Reduced 4.38%	89,384 $6.81 Million
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $210,258 - $263,078	2,915 Added 3.22%	93,479 $8.28 Million
Q3 2019 Dec 04, 2019	BUY	$62.98 - $75.72 $538,982 - $648,011	8,558 Added 10.44%	90,564 $6.86 Million
Q4 2018 Feb 21, 2019	SELL	$77.85 - $96.01 $95,755 - $118,092	-1,230 Reduced 1.48%	82,006 $7.49 Million
Q3 2018 Nov 15, 2018	BUY	$88.91 - $98.84 $7.4 Million - $8.23 Million	83,236 New	83,236 $7.87 Million

Others Institutions Holding ABBV

# of Institutions

3,846

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $297B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Resources Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Resources Management Corp with notifications on news.

Account

Resources Management Corp Abb Vie Inc. Transaction History